With the discovery of penicillin, the first naturally-occurring antibiotic, in 1928, and its mass production in the early 1940s, infections with Staphylococcus aureus were mostly treatable, without any major complications. However, clinicians soon observed the emergence of penicillin-resistant strains of S. aureus, which was largely driven by bacterial expression of beta-lactamases. Methicillin, a novel penicillin analogue that was resistant to beta-lactamases, was introduced in 1959, and was initially effective against penicillin-resistant S. aureus strains. Browse Full Report With TOC @ http://www.researchmoz.us/pharmapoint-methicillin-resistant-staphylococcus-aureus-mrsa-global-drug-forecast-and-market-analysis-to-2024-report.html
http://www.researchmoz.us/pharmapoint-methicillin-resistant-staphylococcus-aureus-mrsa-global-drug-forecast-and-market-analysis-to-2024-report.html
No comments:
Post a Comment